At HTL Biotechnology, we put our expertise in biopolymers at the service of medical innovation. With 100% French-based production and the highest quality standards, we support laboratories worldwide in developing safe, effective, and sustainable therapeutic solutions.

Moments like these are essential to anticipate market evolutions and to continue building, together with our partners, the innovations of tomorrow.

Ophthalmic diseases affect millions of patients worldwide and demand innovative, reliable, and differentiating solutions. We strongly believe that biopolymers have the potential to transform how these conditions are treated.

By supporting hydration, ocular protection, and serving as vectors for innovative drug delivery strategies, these biomaterials are becoming essential allies for the therapies of tomorrow.

At ESCRS 2025, we shared our conviction: ophthalmology is entering a new era, and HTL Biotechnology is proud to contribute to this transformation alongside its partners.

Feel the difference with HTL Inside.

To see our most recent news,
follow us on LinkedIn

Go to our LinkedIn page

Read more
news from us